(Q38038437)

27 August 2017

title

Multiple sclerosis and pregnancy: therapeutic considerations (English)

1 reference

27 August 2017

0 references

Maria K Houtchens

1

1 reference

27 August 2017

Channa M Kolb

series ordinal

2

1 reference

27 August 2017

publication date

25 August 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

260

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

1202-1214

1 reference

Economic burden of multiple sclerosis: a systematic review of the literature

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

The impact of increasing neurological disability of multiple sclerosis on health utilities: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post‐partum relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Pregnancy and multiple sclerosis: the children of PRIMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Estrogens as potential therapeutic agents in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Long-term effects of childbirth in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Multiple sclerosis gender issues: clinical practices of women neurologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

The Brazilian database on pregnancy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Parenthood and immunomodulation in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an alpha4 integrin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Embryo/fetal development in cynomolgus monkeys exposed to natalizumab, an alpha4 integrin inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Effects of natalizumab, an alpha4 integrin inhibitor, on the development of Hartley guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Effects of natalizumab, an alpha4 integrin inhibitor, on fertility in male and female guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

The first case of mitoxantrone exposure in early pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Mitoxantrone: benefits and risks in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Immunomodulation and postpartum relapses in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Breastfeeding is not related to postpartum relapses in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

The use of iodinated and gadolinium contrast media during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Secretion of prednisolone into breast milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Multiple sclerosis: management issues during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6653-9

Pregnancy and multiple sclerosis: a 2-year experience

21 January 2018

1 reference

12 December 2020

Delivery of healthy babies after natalizumab use for multiple sclerosis: a report of two cases

1 reference

12 December 2020

Cost and health related quality of life consequences of multiple sclerosis

1 reference

12 December 2020

Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland

1 reference

12 December 2020

Effect of pregnancy on the prognosis for multiple sclerosis. A 5-year follow up investigation.

1 reference

12 December 2020

Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series

1 reference

12 December 2020

A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis

1 reference

12 December 2020

The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort

1 reference

12 December 2020

Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis

1 reference

12 December 2020

Pharmacokinetics of prednisolone transfer to breast milk

1 reference

12 December 2020

High dose IVIG in the post partum period for prevention of exacerbations in MS

1 reference

12 December 2020

Drugs in pregnancy--the issues for 2010

1 reference

12 December 2020

Pregnancy and multiple sclerosis

1 reference

12 December 2020

Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding

1 reference

12 December 2020

Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis

1 reference

12 December 2020

Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases

1 reference

12 December 2020

Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth

1 reference

12 December 2020

Estimated pregnancy rates and rates of pregnancy outcomes for the United States, 1990-2008.

1 reference

12 December 2020

Pregnancy and multiple sclerosis

1 reference

12 December 2020

Pregnancy and multiple sclerosis

1 reference

12 December 2020

All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States.

1 reference

12 December 2020

Transfer of interferon β-1a into human breastmilk

1 reference

12 December 2020

Prednisolone excretion in human milk

1 reference

12 December 2020

Protective effect of breastfeeding in postpartum relapse rate of mothers with multiple sclerosis

1 reference

12 December 2020

10.1007/S00415-012-6653-9

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1029283113

0 references

1 reference